President Donald Trump speaks during a news conference on the North Portico of the White House, Monday, Sept. 7, 2020 (Patrick Semansky/AP Images)
September 8, 2020 06:35 AM EDTUpdated 10:56 AM
Bioregnum
Coronavirus
Opinion

CEOs join reg­u­la­tors and top sci­en­tists vow­ing to hold the line on Covid-19 vac­cine. But will that get in the way of Trump's 'big sur­prise'?

Nine top de­vel­op­ers lead­ing the race to de­vel­op a vac­cine to com­bat Covid-19 are pre­sent­ing a uni­fied front this morn­ing as they joint­ly com­mit …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

GSK de­fi­ant against vac­cine chal­lenges, will pri­or­i­tize oth­er growth ar­eas

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

No­vo Nordisk sees growth slow­ing this year, plans Ca­griSe­ma fil­ing for 2026

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

Drug­mak­ers seize on bio­mark­ers to test the FDA's rare dis­ease shift

A service from the Financial Times